News

Featured Article

Childhood cancer leader’s star on the rise at NSW Premier’s Science and Engineering Prizes

Internationally recognised leader in childhood cancer research and nanomedicine therapeutics, Professor Maria Kavallaris, has won a 2017 NSW Premier’s Prize for Science and Engineering. The Prize...

Professor Maria Kavallaris

Childhood cancer leader’s star on the rise at NSW Premier’s Science and Engineering Prizes

October 23, 2017

Professor Maria Kavallaris, has won a 2017 NSW Premier’s Prize for Science and Engineering.

Researcher working at fumehood

Grant to speed development of treatments to overcome cancer drug resistance

October 17, 2017

Researchers have been awarded a 3-year $840K Development Grant to test inhibitors of MRP1, a protein which ejects chemotherapy drugs from cancer cells, in a bid to improve patient survival.

Children with most aggressive cancers to benefit from Australian-first personalised medicine clinical trial

September 18, 2017

Personalised medicine for childhood cancers in Australia is a step closer thanks to the Zero Childhood Cancer program’s national clinical trial launched today.

Networks of blood vessels forming from endothelial cells in the absence of dextran-catechin

Tumour blood supply stopped in its tracks

August 9, 2017

Researchers have discovered how a modified natural compound disrupts angiogenesis, the formation of blood vessel networks, in neuroblastoma tumours, stopping them laying down the vital supply lines that fuel cancer growth and spread.

Professor Michelle Haber AM, Executive Director

Leader in childhood cancer research a Eureka Prize finalist

July 28, 2017

Professor Michelle Haber AM, of Children's Cancer Institute and UNSW, was today announced as a finalist for the 2017 Australian Museum Eureka Prize for Leadership in Innovation and Science, sponsored by CSIRO.

$1.3M for neuroblastoma treatments

February 15, 2017

Three grants totalling almost $1.3 million have been awarded to researchers from Children’s Cancer Institute to investigate new treatments for neuroblastoma.

Treatment search for neuroblastoma gets $6.6M boost

February 8, 2017

New treatment approaches could emerge from research into the cancer that claims more lives of under 5s than any other

Michael Brydon (Sydney Children's Hospitals Network), Michelle Haber (Children's Cancer Institute) and Roger Reddel (Children's Medical Research Institute) at the Paediatrio launch

NSW to become world leader in paediatric research with Australia-first collaboration

December 13, 2016

Introducing Paediatrio, an innovative joint venture that will enable NSW to set the national agenda for child health.

DIPG researcher Dr Han Shen in the lab

NHMRC support for exciting new children’s cancer research

December 8, 2016

The search for improved treatments for children’s cancers, including innovative research into a currently incurable brain cancer, will take a big step forward as the NHMRC announced funding totalling $4.5M for Children’s Cancer Institute.

$20M from Federal Government for Personalised Medicine Program Zero Childhood Cancer

November 3, 2016

The Prime Minister presented a cheque today for $20M to support Australia’s single-biggest initiative in childhood cancer research, the Zero Childhood Cancer national child cancer personalised medicine program.

Professor Maria Kavallaris elected AAHMS Fellow

October 7, 2016

Professor Maria Kavallaris of Children’s Cancer Institute has been inducted as a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).

Children’s Cancer Institute celebrates 40th anniversary

September 29, 2016

In 1975, two parents heard some of the most devastating words imaginable, “Your child has cancer.”

Blood ‘hot study’ shows potential for leukaemia drug

September 26, 2016

A ‘breakthrough’ adult leukaemia therapy called venetoclax could successfully target high-risk leukaemia subtypes in infants or children reveals an Australian study published this month, Childhood Cancer Awareness Month, in prestigious US haematology journal Blood.

Drug Discovery Centre robot

Robots play major role in tailoring treatment for kids’ high-risk cancers

September 2, 2016

Thanks to a $1.5M grant from the Australian Cancer Research Foundation (ACRF), the new ACRF Child Cancer Personalised Medicine Centre’s specialised robots can now rapidly test hundreds of treatments for kids with high-risk cancers to guide their care.

Cells under microscope

Fresh look at cancer’s secret of eternal youth

August 18, 2016

Recent advances in drug discovery technology and molecular studies could yield a suite of potential drugs that target cancer’s secret of eternal youth, argue Australian researchers in a Nature Reviews Cancer paper this month.

Disruptive protein opens doors to spread tumours

June 21, 2016

Much like the remote control on a garage door, stathmin sends signals that let cancer cells into and out of blood vessels.

Child blowing bubbles

Childhood cancer cells face testing future

June 19, 2016

In the future, simple blood tests for circulating tumour cells or DNA could be an efficient and non-invasive way to track changes in patients with one of childhood’s more common cancers, neuroblastoma.

Bench to bedside research for childhood cancer gets funding boost

June 9, 2016

Children’s Cancer Institute, one of six partners in the Kids Cancer Alliance, was a major recipient of translational research grants from the Cancer Institute NSW.

Prime Minister announces major funding commitment for Zero Childhood Cancer

May 31, 2016

We are delighted that the Prime Minister has announced today a $20M funding commitment for Australia’s single-biggest initiative in childhood cancer, the Zero Childhood Cancer Program.

Professor Michelle Haber AM, Executive Director

Landmark Lions project to provide genome sequencing to hundreds of Aussie kids with cancer

May 14, 2016

Children’s Cancer Institute is proud to share the news that hundreds of Australian children with high-risk cancer will have access to new genome sequencing technologies that could guide their treatment, following the announcement today of substantial Lions Club funding for the Lions Kids Cancer Genome Project – an important new component of the Zero Childhood Cancer Program for diagnosis and treatment of childhood cancer.

Old drug may offer new hope to cancer patients

March 10, 2016

Who says you can’t teach an old dog new tricks? It seems drugs that have been around for years can sometimes do something spectacular when applied in a whole new way.

Cancer Council NSW Program Grant funds our multi-faceted leukaemia research

December 19, 2015

Cancer Council NSW has awarded Children’s Cancer Institute its fourth consecutive 5-year Program Grant to research ways of improving treatments for children with ‘refractory’ acute lymphoblastic leukaemia (ALL) – in other words, children diagnosed with a high-risk subtype of the disease, or who have received treatment and have subsequently relapsed.

Notice of change of Auditor

December 14, 2015

Children's Cancer Institute ('the Institute') hereby advises that the Australian Securities and Investments Commission (ASIC) have consented to the resignation of the Institute's auditors, Moore Stephens, effective from the date of the attached notice.

Professor Maria Kavallaris

Professor Maria Kavallaris one of ‘The Knowledge Nation 100’

December 10, 2015

Professor Maria Kavallaris from Children’s Cancer Institute has been recognised as one of ‘The Knowledge Nation 100’ - Australia’s top 100 “visionaries, intellects, founders and game changers” who will help shape the country’s future prosperity.

Dr Dan Carter and Dr Vincent Jing

Promising child cancer researchers supported by Balnaves Foundation

November 11, 2015

Two inspiring postdoctoral researchers from Children’s Cancer Institute, Dr Daniel Carter and Dr Duohui (Vincent) Jing, are recipients of the 2015 Balnaves Foundation Young Researcher’s Fund. The Balnaves Foundation, a private philanthropic organisation set up by Neil Balnaves AO in 2006, has awarded each researcher $100,000 to explore uncharted territory in childhood cancer.

Dr Dan Carter and Jayne Murray

A way to target the Achilles heel of neuroblastoma

November 5, 2015

Australian scientists have identified a critical molecular ‘feedback loop’ that helps initiate and drive neuroblastoma, a cancer of the nervous system in children that is triggered in embryonal nerve cells.

Our finest researchers among finalists in The Australian Innovation Challenge

October 24, 2015

A team of inspirational child cancer researchers – Professors Glenn Marshall, Michelle Haber and Murray Norris – have been selected as finalists in the Health category of The Australian Innovation Challenge, announced in The Australian newspaper today.

Professor Maria Kavallaris one of The Australian Financial Review and Westpac’s 100 Women of Influence 2015

September 24, 2015

Professor Maria Kavallaris, Head of the Tumour Biology & Targeting Program at Children's Cancer Institute and founding Director of the Australian Centre for NanoMedicine at UNSW Australia, has been named one of The Australian Financial Review and Westpac’s 100 Women of Influence 2015.

Fast-tracking new drugs for childhood acute leukaemia

September 9, 2015

Children’s Cancer Institute welcomes its inclusion, by the US National Cancer Institute (NCI), in a systematic program of drug evaluation in childhood cancer.

Zero Childhood Cancer program aims to push survival rates to 100%

September 2, 2015

Children’s Cancer Institute and Sydney Children’s Hospital, Randwick (part of The Sydney Children’s Hospitals Network) are proud to announce one of the most exciting childhood cancer research initiatives ever undertaken in Australia, to tackle the most serious cases of infant, childhood and adolescent cancer. Launched today at Children’s Cancer Institute, ‘Zero Childhood Cancer’ gives hope to children with the highest risk of treatment failure or relapse.

Professor Maria Kavallaris

Professor Maria Kavallaris appointed to NHMRC Research Committee

August 25, 2015

The CEO of the NHMRC Professor Anne Kelso, today announced the appointment of Professor Maria Kavallaris, Head of the Tumour Biology & Targeting Program at Children's Cancer Institute, to the Research Committee of the National Health and Medical Research Council (NHMRC).

Children’s Cancer Institute signs MoU with Peter Mac

July 21, 2015

Children’s Cancer Institute is delighted to announce the strengthening and formalisation of its relationship with Melbourne’s Peter MacCallum Cancer Centre through a Memorandum of Understanding (MoU) that specifies areas of collaboration in cancer research for children and adolescents.

Research sector celebrates passage of Medical Research Future Fund Bill

August 12, 2015

Today’s passing of the legislation for the Medical Research Future Fund (MRFF) in the Senate has brought hope not just to the Australian health and medical research sector but also to the entire country, according to the Association of Australian Medical Research Institutes (AAMRI).

Professor Richard Lock

Promising drug for childhood acute leukaemia – where to next

July 10, 2015

A new Australian study shows that a recently-developed drug, already used safely in adult leukaemia clinical trials1, holds great promise for some children with an aggressive form of cancer known as acute lymphoblastic leukaemia (ALL).

25 Million for Paediatric Research

June 18, 2015

Minister for Health Jillian Skinner and Minister for Medical Research Pru Goward have visited The Children’s Hospital at Westmead to announce the 2015-16 Budget will include $25 million for paediatric research to unlock treatments and cures.

Murray Norris

Deputy Director appointed AM

June 8, 2015

Children’s Cancer Institute is thrilled to announce that our Deputy Director, Professor Murray Norris, has been appointed a Member of the Order of Australia as part of the 2015 Queen’s Birthday Honours List for outstanding achievement and contribution in the field of childhood cancer research.

cure starts now

Children’s Cancer Institute and The Cure Starts Now join forces

March 27, 2015

Townsville based cancer research foundation, The Cure Starts Now (Australia), has granted Children’s Cancer Institute another $100,000 to expand research in to Diffuse Intrinsic Pontine Glioma (DIPG) – the most aggressive and deadly of all childhood cancers.

aahms

Michelle Haber inaugural fellow AAHMS

March 26, 2015

Children’s Cancer Institute is pleased to announce that our Executive Director, Professor Michelle Haber AM, has been elected as a Fellow of the newly formed Australian Academy of Health & Medical Sciences (AAHMS).

Children’s Cancer Institute awarded grant by NHMRC

March 25, 2015

A team led by Children’s Cancer Institute researchers has been awarded a grant by the National Health & Medical Research Council (NHMRC), announced today by the Minister for Health, the Hon Sussan Ley MP, for its innovative work into two of the most aggressive types of childhood cancer.

Cancer Institute NSW Program Grants

March 5, 2015

Children's Cancer Institute's outstanding research work has been recognised by the Cancer Institute NSW's Translational Program Grants, announced yesterday by NSW Minister for Health and Medical Research, The Hon Jillian Skinner MP.

Drug pinpointed for aggressive leukaemia

February 26, 2015

Children’s Cancer Institute researchers have identified a drug as a potential treatment for a particularly aggressive, chemotherapy-resistant type of paediatric leukaemia.

State wide investment in child research

February 24, 2015

Children’s Cancer Institute is delighted to be one of three recipients of a ground-breaking investment by the state government into paediatric medical research.

Balnaves award to two researchers

February 9, 2015

The Balnaves Foundation has once again shown its commitment to curing childhood cancer by awarding two aspiring researchers at Children’s Cancer Institute the Balnaves Young Researcher of the Year Award 2014.

Commitment to MRFF

December 15, 2014

Children's Cancer Institute has welcomed the announcement by the Prime Minister and the Minister for Health of a new funding package to see the $20 billion Medical Research Future Fund (MRFF) realised.

Cancer stem cell world first

December 12, 2014

Children’s Cancer Institute researchers have identified, for the first time, new properties essential to drug-resistant tumour cells that could revolutionise cancer treatment and reduce the side-effects of chemotherapy.

acrf

Australian first child cancer medicine centre

November 13, 2014

Children’s Cancer Institute has been awarded a grant of $1.5 million for the establishment of a precision medicine centre. The centre heralds a new era in childhood cancer research and treatment and has the very real potential to substantially improve patient outcomes and survival rates.

Milestone hit on journey to a cure

November 7, 2014

Researchers have made an important step towards a 100% survival rate for the most common type of childhood cancer, with the latest findings of a trial for children with relapsed acute lymphoblastic leukaemia confirming the superiority of a chemotherapy drug for treating the disease.

New drug potential for child leukaemia

October 17, 2014

Researchers from Children’s Cancer Institute have uncovered a potential new treatment for acute lymphoblastic leukaemia – the most common form of childhood cancer.

mrp4 feature

Abcam licenses MRP4 from Institute

September 19, 2014

Compounds allow further exploration of MRP4 function and have potential in cancer therapeutic development

Ground breaking clinical trial for childhood cancer

September 2, 2014

New trial offers exciting new treatment approach for aggressive relapsed neuroblastoma

Michelle Haber

Michelle Haber wins top award

August 23, 2014

Children’s Cancer Institute is thrilled to announce that our Executive Director, Professor Michelle Haber AM, has been awarded the Premier’s Award for Outstanding Cancer Researcher of the Year 2014, in recognition of her significant contribution to research into childhood cancer.

tao research

New target for cancer therapy

August 4, 2014

Researchers at Children’s Cancer Institute have uncovered, for the first time, another gene linked to the cause of one of the most aggressive forms of childhood cancer – that could provide new targets for cancer therapy and change the way we treat the disease.

Governor General announced as Patron

July 28, 2014

Children’s Cancer Institute is extremely proud to announce that His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), Governor-General of the Commonwealth of Australia, has become a Patron for our organisation.

byrne

The Byrne Family Story

June 30, 2014

Brian and Glenda Byrne have endured the almost unbelievable heartbreak of losing three of their four sons - in completely unrelated incidents. Following the death of their youngest son, Kieran, from a rare form of childhood cancer, their only surviving son, Brendan, received harrowing news about his own daughter, Matilda. Watch as the family tells its fascinating story.

30 years closer

30 years closer

May 26, 2014

Internationally renowned medical research organisation, Children’s Cancer Institute, is this year celebrating 30 years since its lab doors first opened. The milestone was officially launched today at the Institute’s Annual General Meeting.

Meet Hugo

Personalised medicine explained

May 2, 2014

As we celebrate 30 years of dedicated medical research into childhood cancer, we are very excited to be at the forefront of a new era in childhood cancer treatment: personalised medicine.

Neuroblastoma: Our battle

May 2, 2014

“While it’s tough knowing there are children out there suffering with the disease, staying positive isn’t that hard. The courage of children, and their parents, is an incredible inspiration.” - Dr Daniel Carter

Endure for a cure 2014

April 9, 2014

On Friday 4 April, close to 100 keen cyclists put foot to pedal at Sydney Motor Sport Park, Eastern Creek in an incredible display of endurance to cure kids’ cancer.

cci old logo

Our brand has changed. Our purpose won’t.

March 27, 2014

Children's Cancer Institute unveils a new look as we celebrate 30 years since we first opened our lab doors.

state govt funding

New era in childhood cancer treatment

March 3, 2014

Children’s Cancer Institute is proud to announce its personalised medicine program for children with cancer as a key partner of the newly-funded Cancer Therapeutics Cooperative Research Centre (CTx).

Researchers uncover cause of childhood leukaemia

September 25, 2013

Australian researchers at Children's Cancer Institute and Sydney Children's Hospital are part of an international research collaboration that has discovered a genetic link specific to the risk of childhood leukaemia.

research cancer

Green tea extract potential

August 5, 2013

Children's Cancer Institute researcher, Dr Orazio Vittorio, was awarded the inaugural Kids' Cancer Project award at the NSW Premier's Awards for Outstanding Cancer Research for research looking at the anti-cancer properties of an antioxidant.

Old drugs bring new hope

May 23, 2013

Researchers at Children's Cancer Institute have discovered that beta-blockers, traditionally used in the treatment of hypertension, can increase the effectiveness of chemotherapy in childhood cancers, such as neuroblastoma.

Antibody drug new hope for blood cancer

April 22, 2013

Researchers at Children's Cancer Institute have shown that a new antibody-based drug has the potential to improve the survival rate for children who relapse from one of the most common types of paediatric blood cancers: acute lymphoblastic leukaemia.

Stay up to date with our news, social media channels like Facebook, twitter and Instagram.  Gain insight in to whats happening in our news and media world.